Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Menorrhagia × linzagolix × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 3 Menorrhagia 1

Interventions

estradiol, norethindrone drug combination 6 elagolix 6 asoprisnil 6 Uterine Artery Embolization 6 Estradiol 5 vilaprisan 4 Uterine Myomectomy 4 Norethindrone Acetate 4 relugolix 3 Tranexamic Acid 2 ziprasidone 1 ulipristal acetate 1 ulipristal 1 pycnogenols 1 linzagolix 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Radiofrequency Ablation 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03070951 2021-03-05

PRIMROSE 2

ObsEva SA

Phase 3 Completed

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡